Search Results - "AHLBERG, L"
-
1
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
Published in Haematologica (Roma) (01-03-2018)“…Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent 'real-world' patients. The…”
Get full text
Journal Article -
2
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study
Published in Leukemia (01-04-2007)“…This randomized study assessed if intravenous iron improves hemoglobin (Hb) response and permits decreased epoetin dose in anemic (Hb 9-11 g/dl),…”
Get full text
Journal Article -
3
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009
Published in Bone marrow transplantation (Basingstoke) (01-12-2016)“…High-dose melphalan and autologous stem cell transplantation (HDM/ASCT) is widely used in immunoglobulin light chain (AL) amyloidosis, but the benefit is…”
Get full text
Journal Article -
4
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
Published in Bone marrow transplantation (Basingstoke) (01-11-2013)“…Outcomes and prognostic factors of reduced intensity-conditioned allo-SCT (RIC allo-SCT) for multiple myeloma (MM) relapsing or progressing after prior…”
Get full text
Journal Article -
5
RELAPSE OF ACUTE LYMPHOBLASTIC LEUKAEMIA IN OLDER/ELDERLY PATIENTS: A SWEDISH POPULATION-BASED STUDY
Published in HAEMATOLOGICA (2016)Get full text
Journal Article Conference Proceeding -
6
Prognosis in older/elderly patients with acute lymphoblastic leukaemia diagnosed 2005-2012: results from a Swedish population-based study
Published in HAEMATOLOGICA (2015)Get full text
Journal Article Conference Proceeding -
7
THE REVII TRIAL: LENALIDOMIDE AND DEXAMETHASONE AS SECOND LINE TREATMENT IN MYELOMA FOLLOWED BY EXTENDED LENALIDOMID VS LEN/DEX
Published in HAEMATOLOGICA (2014)Get full text
Journal Article Conference Proceeding -
8
MINIMAL RESIDUAL DISEASE IN ADULTS WITH PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA A SWEDISH POPULATION-BASED STUDY
Published in HAEMATOLOGICA (2014)Get full text
Journal Article Conference Proceeding -
9
Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study
Published in Medical oncology (Northwood, London, England) (2014)“…Even in the tyrosine kinase inhibitor era, allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as standard care for adult Philadelphia (Ph)…”
Get full text
Journal Article -
10
Agrarian Crossings: Reformers and the Remaking of the US and Mexican Countryside by Tore C. Olsson (review)
Published in The Journal of southern history (2018)Get full text
Journal Article -
11
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study
Published in LEUKEMIA (01-02-2008)Get full text
Journal Article Publication -
12
Inequalities in health: a comparative study between ethnic Norwegians and Pakistanis in Oslo, Norway
Published in International journal for equity in health (29-06-2006)“…The objective of the study was to observe the inequality in health from the perspective of socio-economic factors in relation to ethnic Pakistanis and ethnic…”
Get full text
Journal Article -
13
"Machiavelli with a Heart": The Johnson Administration's Food for Peace Program in India, 1965–1966
Published in Diplomatic history (01-09-2007)“…Ahlberg, drawing upon newly declassified and opened LBJ Library document collections and taped telephone conservations, examines the hypothesis that Pres…”
Get full text
Journal Article -
14
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Published in Blood (06-06-2013)“…The Nordic Myeloma Study Group conducted an open randomized trial to compare bortezomib as consolidation therapy given after high-dose therapy and autologous…”
Get full text
Journal Article -
15
Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
Published in European journal of haematology (01-08-2019)“…Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care…”
Get full text
Journal Article -
16
Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden
Published in European journal of haematology (01-08-2017)“…Objectives Older/elderly patients with acute lymphoblastic leukemia (ALL) are poorly represented in clinical trials. Methods Using Swedish national leukemia…”
Get full text
Journal Article -
17
Building a Model Public History Program: The Office of the Historian at the U.S. Department of State
Published in The Public historian (01-05-2008)“…The Office of the Historian at the U.S. Department of State, responsible for the production and publication of theForeign Relations of the United Statesseries,…”
Get full text
Journal Article -
18
A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Published in BLOOD (05-11-2020)“…Introduction Autologous stem cell transplantation (ASCT) combined with novel agents is considered as the standard treatment for eligible patients < 70(-75)…”
Get full text
Journal Article Conference Proceeding -
19
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial
Published in Cancer chemotherapy and pharmacology (01-01-2018)“…Purpose Despite therapeutic advances, patients with multiple myeloma (MM) continue to experience disease relapse and treatment resistance. The gene ABCB1…”
Get full text
Journal Article -
20
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
Published in Blood (01-06-2005)“…We report the outcome of 229 patients who received an allograft for myeloma with reduced-intensity conditioning (RIC) regimens from 33 centers within the…”
Get full text
Journal Article